{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:09:51Z","timestamp":1782821391321,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shandong Province Medical and Health Technology Development Plan Project","award":["202103100394"],"award-info":[{"award-number":["202103100394"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cytotechnology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10616-024-00632-3","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:01:41Z","timestamp":1715857301000},"page":"503-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Heparanase accelerates the angiogenesis and inhibits the ferroptosis of p53-mutant non-small cell cancers in VEGF-dependent manner"],"prefix":"10.1007","volume":"76","author":[{"given":"Yaobo","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"632_CR1","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1038\/sj.onc.1209425","volume":"25","author":"L Baraz","year":"2006","unstructured":"Baraz L, Haupt Y, Elkin M, Peretz T, Vlodavsky I (2006) Tumor suppressor p53 regulates heparanase gene expression. Oncogene 25:3939\u20133947. https:\/\/doi.org\/10.1038\/sj.onc.1209425","journal-title":"Oncogene"},{"key":"632_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc2693","volume":"9","author":"R Brosh","year":"2009","unstructured":"Brosh R, Rotter V (2009) When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 9:701\u2013713. https:\/\/doi.org\/10.1038\/nrc2693","journal-title":"Nat Rev Cancer"},{"key":"632_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/abbs\/gms109","volume":"45","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhu L, Li X, Tian H, Fang Y, Liu H, Li S, Li L, Yue W, Li W (2013) Down-regulation of heparanase leads to the inhibition of invasion and proliferation of A549 cells in vitro and in vivo. Acta Biochim Biophys Sin 45:188\u2013193. https:\/\/doi.org\/10.1093\/abbs\/gms109","journal-title":"Acta Biochim Biophys Sin"},{"key":"632_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D (2021) Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 18:280\u2013296. https:\/\/doi.org\/10.1038\/s41571-020-00462-0","journal-title":"Nat Rev Clin Oncol"},{"key":"632_CR5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/cncr.23680","volume":"113","author":"E Cohen","year":"2008","unstructured":"Cohen E, Doweck I, Naroditsky I, Ben-Izhak O, Kremer R, Best LA, Vlodavsky I, Ilan N (2008) Heparanase is overexpressed in lung cancer and correlates inversely with patient survival. Cancer 113:1004\u20131011. https:\/\/doi.org\/10.1002\/cncr.23680","journal-title":"Cancer"},{"key":"632_CR6","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/ijc.23898","volume":"123","author":"V Cohen-Kaplan","year":"2008","unstructured":"Cohen-Kaplan V, Naroditsky I, Zetser A, Ilan N, Vlodavsky I, Doweck I (2008) Heparanase induces VEGF C and facilitates tumor lymphangiogenesis. Int J Cancer 123:2566\u20132573. https:\/\/doi.org\/10.1002\/ijc.23898","journal-title":"Int J Cancer"},{"key":"632_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/JTO.0b013e3181a4b8fb","volume":"4","author":"AB Custodio","year":"2009","unstructured":"Custodio AB, Gonz\u00e1lez-Larriba JL, Bobokova J, Calles A, Alvarez R, Cuadrado E, Manzano A, D\u00edaz-Rubio E (2009) Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 4:891\u2013910. https:\/\/doi.org\/10.1097\/JTO.0b013e3181a4b8fb","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"632_CR8","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"JS Fridman","year":"2003","unstructured":"Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22:9030\u20139040. https:\/\/doi.org\/10.1038\/sj.onc.1207116","journal-title":"Oncogene"},{"key":"632_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520:57\u201362. https:\/\/doi.org\/10.1038\/nature14344","journal-title":"Nature"},{"key":"632_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/blood-2013-09-512749","volume":"123","author":"YW Kim","year":"2014","unstructured":"Kim YW, Byzova TV (2014) Oxidative stress in angiogenesis and vascular disease. Blood 123:625\u2013631. https:\/\/doi.org\/10.1182\/blood-2013-09-512749","journal-title":"Blood"},{"key":"632_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2017.05.103","volume":"489","author":"MG Kim","year":"2017","unstructured":"Kim MG, Jo SD, Yhee JY, Lee BS, Lee SJ, Park SG, Kang SW, Kim SH, Jeong JH (2017) Synergistic anti-tumor effects of bevacizumab and tumor targeted polymerized VEGF siRNA nanoparticles. Biochem Biophys Res Commun 489:35\u201341. https:\/\/doi.org\/10.1016\/j.bbrc.2017.05.103","journal-title":"Biochem Biophys Res Commun"},{"key":"632_CR12","doi-asserted-by":"publisher","first-page":"101365","DOI":"10.1016\/j.jbc.2021.101365","volume":"297","author":"N Kuganesan","year":"2021","unstructured":"Kuganesan N, Dlamini S, Tillekeratne LMV, Taylor WR (2021) Tumor suppressor p53 promotes ferroptosis in oxidative stress conditions independent of modulation of ferroptosis by p21, CDKs, RB, and E2F. J Biol Chem 297:101365. https:\/\/doi.org\/10.1016\/j.jbc.2021.101365","journal-title":"J Biol Chem"},{"key":"632_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.humpath.2014.07.026","volume":"46","author":"B Lei","year":"2015","unstructured":"Lei B, Qi W, Zhao Y, Li Y, Liu S, Xu X, Zhi C, Wan L, Shen H (2015) PBK\/TOPK expression correlates with mutant p53 and affects patients\u2019 prognosis and cell proliferation and viability in lung adenocarcinoma. Hum Pathol 46:217\u2013224. https:\/\/doi.org\/10.1016\/j.humpath.2014.07.026","journal-title":"Hum Pathol"},{"key":"632_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/jcb.20700","volume":"97","author":"G Liu","year":"2006","unstructured":"Liu G, Chen X (2006) Regulation of the p53 transcriptional activity. J Cell Biochem 97:448\u2013458. https:\/\/doi.org\/10.1002\/jcb.20700","journal-title":"J Cell Biochem"},{"key":"632_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","volume":"29","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W (2022) p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ 29:895\u2013910. https:\/\/doi.org\/10.1038\/s41418-022-00943-y","journal-title":"Cell Death Differ"},{"key":"632_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.clon.2013.09.003","volume":"26","author":"X Liu","year":"2014","unstructured":"Liu X, Lin XJ, Wang CP, Yan KK, Zhao LY, An WX, Liu XD (2014) Association between smoking and p53 mutation in lung cancer: a meta-analysis. Clin Oncol (royal College of Radiologists (great Britain)) 26:18\u201324. https:\/\/doi.org\/10.1016\/j.clon.2013.09.003","journal-title":"Clin Oncol (royal College of Radiologists (great Britain))"},{"key":"632_CR17","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3892\/ol.2016.4085","volume":"11","author":"B Lv","year":"2016","unstructured":"Lv B, Zhang B, Hu XY, Zeng QD (2016) Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma. Oncol Lett 11:1327\u20131334. https:\/\/doi.org\/10.3892\/ol.2016.4085","journal-title":"Oncol Lett"},{"key":"632_CR18","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3892\/ijo.2018.4503","volume":"53","author":"Q Lv","year":"2018","unstructured":"Lv Q, Wu K, Liu F, Wu W, Chen Y, Zhang W (2018) Interleukin-17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer. Int J Oncol 53:1809\u20131817. https:\/\/doi.org\/10.3892\/ijo.2018.4503","journal-title":"Int J Oncol"},{"key":"632_CR19","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.4161\/cc.10.15.16585","volume":"10","author":"UE Martinez-Outschoorn","year":"2011","unstructured":"Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP (2011) Cancer cells metabolically \u201cfertilize\u201d the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle (Georgetown, Tex.) 10:2504\u20132520. https:\/\/doi.org\/10.4161\/cc.10.15.16585","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"632_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells7120236","author":"V Masola","year":"2018","unstructured":"Masola V, Bellin G, Gambaro G, Onisto M (2018) Heparanase: a multitasking protein involved in extracellular matrix (ECM) remodeling and intracellular events. Cells. https:\/\/doi.org\/10.3390\/cells7120236","journal-title":"Cells"},{"key":"632_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2019.07.014","volume":"62","author":"V Masola","year":"2020","unstructured":"Masola V, Zaza G, Gambaro G, Franchi M, Onisto M (2020) Role of heparanase in tumor progression: molecular aspects and therapeutic options. Semin Cancer Biol 62:86\u201398. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.014","journal-title":"Semin Cancer Biol"},{"key":"632_CR22","doi-asserted-by":"publisher","first-page":"583929","DOI":"10.1155\/2011\/583929","volume":"2011","author":"A Mogi","year":"2011","unstructured":"Mogi A, Kuwano H (2011) TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol 2011:583929. https:\/\/doi.org\/10.1155\/2011\/583929","journal-title":"J Biomed Biotechnol"},{"key":"632_CR23","doi-asserted-by":"publisher","first-page":"a001107","DOI":"10.1101\/cshperspect.a001107","volume":"2","author":"M Oren","year":"2010","unstructured":"Oren M, Rotter V (2010) Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2:a001107. https:\/\/doi.org\/10.1101\/cshperspect.a001107","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"632_CR24","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang SJ, Li D, Chu B, Gu W (2016) Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci USA 113:E6806-e6812. https:\/\/doi.org\/10.1073\/pnas.1607152113","journal-title":"Proc Natl Acad Sci USA"},{"key":"632_CR25","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.ajpath.2023.05.003","volume":"193","author":"M Peng","year":"2023","unstructured":"Peng M, Hu Q, Wu Z, Wang B, Wang C, Yu F (2023) Mutation of TP53 confers ferroptosis resistance in lung cancer through the FOXM1\/MEF2C axis. Am J Pathol 193:1587\u20131602. https:\/\/doi.org\/10.1016\/j.ajpath.2023.05.003","journal-title":"Am J Pathol"},{"key":"632_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/antiox6020032","author":"R Prieto-Bermejo","year":"2017","unstructured":"Prieto-Bermejo R, Hern\u00e1ndez-Hern\u00e1ndez A (2017) The importance of NADPH oxidases and redox signaling in angiogenesis. Antioxidants (Basel, Switzerland). https:\/\/doi.org\/10.3390\/antiox6020032","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"632_CR27","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1182\/blood-2009-07-234757","volume":"115","author":"A Purushothaman","year":"2010","unstructured":"Purushothaman A, Uyama T, Kobayashi F, Yamada S, Sugahara K, Rapraeger AC, Sanderson RD (2010) Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 115:2449\u20132457. https:\/\/doi.org\/10.1182\/blood-2009-07-234757","journal-title":"Blood"},{"key":"632_CR28","first-page":"501","volume":"36","author":"A Qadir","year":"2023","unstructured":"Qadir A, Khalid Z, Kashan Theba F, Mujtaba Ali M, Asif M, Rizvi F (2023) Celecoxib and bevacizumab synergistically inhibit non-small cell lung cancer by inducing apoptosis and modulating VEGF and MMP-9 expression. Pak J Pharm Sci 36:501\u2013506","journal-title":"Pak J Pharm Sci"},{"key":"632_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/978-3-030-34521-1_13","volume":"1221","author":"B Tang","year":"2020","unstructured":"Tang B, Yang S (2020) Involvement of heparanase in gastric cancer progression and immunotherapy. Adv Exp Med Biol 1221:351\u2013363. https:\/\/doi.org\/10.1007\/978-3-030-34521-1_13","journal-title":"Adv Exp Med Biol"},{"key":"632_CR30","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1002\/ctm2.390","volume":"11","author":"Z Tang","year":"2021","unstructured":"Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N (2021) Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin Transl Med 11:e390. https:\/\/doi.org\/10.1002\/ctm2.390","journal-title":"Clin Transl Med"},{"key":"632_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2017.12.077","volume":"22","author":"A Tarangelo","year":"2018","unstructured":"Tarangelo A, Magtanong L, Bieging-Rolett KT, Li Y, Ye J, Attardi LD, Dixon SJ (2018) p53 suppresses metabolic stress-induced ferroptosis in cancer cells. Cell Rep 22:569\u2013575. https:\/\/doi.org\/10.1016\/j.celrep.2017.12.077","journal-title":"Cell Rep"},{"key":"632_CR32","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1200\/jco.2007.12.6953","volume":"25","author":"MS Tsao","year":"2007","unstructured":"Tsao MS, Aviel-Ronen S, Ding K, Lau D, Liu N, Sakurada A, Whitehead M, Zhu CQ, Livingston R, Johnson DH, Rigas J, Seymour L, Winton T, Shepherd FA (2007) Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer. J Clin Oncol off J Am Soc Clin Oncol 25:5240\u20135247. https:\/\/doi.org\/10.1200\/jco.2007.12.6953","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"632_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drup.2016.10.001","volume":"29","author":"I Vlodavsky","year":"2016","unstructured":"Vlodavsky I, Singh P, Boyango I, Gutter-Kapon L, Elkin M, Sanderson RD, Ilan N (2016) Heparanase: from basic research to therapeutic applications in cancer and inflammation. Drug Resistance Updates Rev Comment Antimicrob Anticancer Chemother 29:54\u201375. https:\/\/doi.org\/10.1016\/j.drup.2016.10.001","journal-title":"Drug Resistance Updates Rev Comment Antimicrob Anticancer Chemother"},{"key":"632_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tibs.2017.10.007","volume":"43","author":"I Vlodavsky","year":"2018","unstructured":"Vlodavsky I, Gross-Cohen M, Weissmann M, Ilan N, Sanderson RD (2018) Opposing functions of heparanase-1 and heparanase-2 in cancer progression. Trends Biochem Sci 43:18\u201331. https:\/\/doi.org\/10.1016\/j.tibs.2017.10.007","journal-title":"Trends Biochem Sci"},{"key":"632_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40364-021-00338-0","volume":"9","author":"S Wu","year":"2021","unstructured":"Wu S, Zhu C, Tang D, Dou QP, Shen J, Chen X (2021) The role of ferroptosis in lung cancer. Biomark Res 9:82. https:\/\/doi.org\/10.1186\/s40364-021-00338-0","journal-title":"Biomark Res"},{"key":"632_CR36","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","volume":"20","author":"Y Xie","year":"2017","unstructured":"Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, Zhong M, Yuan H, Zhang L, Billiar TR, Lotze MT, Zeh HJ III, Kang R, Kroemer G, Tang D (2017) The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep 20:1692\u20131704. https:\/\/doi.org\/10.1016\/j.celrep.2017.07.055","journal-title":"Cell Rep"},{"key":"632_CR37","doi-asserted-by":"publisher","first-page":"8457521","DOI":"10.1155\/2021\/8457521","volume":"2021","author":"R Xiong","year":"2021","unstructured":"Xiong R, He R, Liu B, Jiang W, Wang B, Li N, Geng Q (2021) Ferroptosis: a new promising target for lung cancer therapy. Oxid Med Cell Longev 2021:8457521. https:\/\/doi.org\/10.1155\/2021\/8457521","journal-title":"Oxid Med Cell Longev"},{"key":"632_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1158\/1541-7786.Mcr-19-0691","volume":"18","author":"WH Yang","year":"2020","unstructured":"Yang WH, Huang Z, Wu J, Ding CC, Murphy SK, Chi JT (2020) A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer. Mol Cancer Res MCR 18:79\u201390. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-0691","journal-title":"Mol Cancer Res MCR"},{"key":"632_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.bbrc.2017.02.060","volume":"485","author":"S Yu","year":"2017","unstructured":"Yu S, Lv H, Zhang H, Jiang Y, Hong Y, Xia R, Zhang Q, Ju W, Jiang L, Ou G, Zhang J, Wang S, Zhang J (2017) Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C\/ERK pathway. Biochem Biophys Res Commun 485:432\u2013439. https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.060","journal-title":"Biochem Biophys Res Commun"},{"key":"632_CR40","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3779\/j.issn.1009-3419.2009.08.06","volume":"12","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Ming J, Li Y, Zhang S, Li B, Qiu X, Wang E (2009) Heparanase expression correlates with angiogenesis and lymphangiogenesis in human lung cancer. Zhongguo Fei Ai Za Zhi = Chin J Lung Cancer 12:864\u2013867. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2009.08.06","journal-title":"Zhongguo Fei Ai Za Zhi = Chin J Lung Cancer"},{"key":"632_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12967-021-02770-0","volume":"19","author":"H Zhang","year":"2021","unstructured":"Zhang H, Xu C, Shi C, Zhang J, Qian T, Wang Z, Ma R, Wu J, Jiang F, Feng J (2021a) Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis. J Transl Med 19:98. https:\/\/doi.org\/10.1186\/s12967-021-02770-0","journal-title":"J Transl Med"},{"key":"632_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/jci152067","author":"W Zhang","year":"2021","unstructured":"Zhang W, Sun Y, Bai L, Zhi L, Yang Y, Zhao Q, Chen C, Qi Y, Gao W, He W, Wang L, Chen D, Fan S, Chen H, Piao HL, Qiao Q, Xu Z, Zhang J, Zhao J, Zhang S, Yin Y, Peng C, Li X, Liu Q, Liu H, Wang Y (2021b) RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J Clin Investig. https:\/\/doi.org\/10.1172\/jci152067","journal-title":"J Clin Investig"}],"container-title":["Cytotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-024-00632-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10616-024-00632-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-024-00632-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T10:36:25Z","timestamp":1724495785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10616-024-00632-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1007\/s10616-024-00632-3","relation":{},"ISSN":["0920-9069","1573-0778"],"issn-type":[{"value":"0920-9069","type":"print"},{"value":"1573-0778","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"9 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our animal experiments were carried out according to the institutional ethics guidelines and National Institute of Health Principles (NIH Pub.2001), and approved by the institutional Animal Care and Use Committee of Yantaishan Hospital (Ethics number: LL-2023-084-K).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}